NEW YORK (GenomeWeb) – The National Institutes of Health today launched a $20 million competition to promote the development of novel point-of-care in vitro diagnostics to detect and distinguish antibiotic-resistant bacteria.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.